Decreased expression of Ki-67 was observed in the LCL161 and paclitaxel co-treatment group, indicating that tumor cell proliferation was significantly inhibited by drugs co-treatment (p < 0.01, Fig. 10b). Here, MKI67 is linked to neoplasm.